Segmentation by type classifies the market into distinct box architectures that address specific logistical and temperature‑control requirements. Passive insulated boxes, typically constructed from expanded polystyrene or foam, dominate the reusable segment, offering cost‑effective protection for short‑haul transport and representing the largest share due to their broad applicability. Active temperature‑controlled containers, equipped with battery‑powered refrigeration or heating units, serve high‑value or temperature‑sensitive specimens, such as RNA samples, and command a premium price point, contributing a smaller yet growing fraction of revenue. Single‑use disposable boxes, made from lightweight corrugated paper with integrated absorbent liners, are favored for biohazard containment and regulatory compliance, especially in high‑throughput settings. Cryogenic boxes, designed for ultra‑low temperatures using dry‑ice or liquid‑nitrogen compartments, address niche markets like stem‑cell and genetic material transport. Biohazard‑rated boxes, featuring puncture‑resistant walls and sealable closures, are mandated for infectious disease specimens, influencing procurement policies across all applications. The relative market weight of each type aligns with the balance between cost constraints, reuse cycles, and the criticality of temperature fidelity.
